{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T01:00:57Z","timestamp":1649206857908},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1157\/13112944","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T20:45:02Z","timestamp":1196801102000},"page":"655-656","source":"Crossref","is-referenced-by-count":0,"title":["A prop\u00f3sito de un paciente con infecci\u00f3n por Salmonella enterica serotipo Typhi resistente al \u00e1cido nalid\u00edxico. Indicaci\u00f3n terap\u00e9utica"],"prefix":"10.1016","volume":"25","author":[{"given":"Juan Jos\u00e9","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Larrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.\u00aa","family":"Planes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.\u00aa","family":"Bartolom\u00e9-Comas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13112944_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever","volume":"366","author":"Bhan","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13112944_bib2","first-page":"539","article-title":"Estudio de cepas multirresistentes de Salmonella Typhi en Espa\u00f1a","volume":"10","author":"Usera","year":"1992","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13112944_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkg222","article-title":"Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection","volume":"51","author":"Ruiz","year":"2003","journal-title":"J Antimicrob Chemoter"},{"key":"10.1157\/13112944_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1128\/AAC.43.9.2131","article-title":"Comparative studies of mutations in animal isolates and experimental in vitroand in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field","volume":"43","author":"Giraud","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13112944_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/1076629041310028","article-title":"Reduced susceptibility to ciproflixacin and gyrA gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A","volume":"10","author":"Renuka","year":"2004","journal-title":"Microb Drug Resist"},{"key":"10.1157\/13112944_bib6","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JCM.37.11.3572-3577.1999","article-title":"Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test","volume":"37","author":"Hakanen","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13112944_bib7","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1128\/AAC.49.5.1775-1781.2005","article-title":"Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype Typhi","volume":"49","author":"Booker","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13112944_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-5-37","article-title":"Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi","volume":"5","author":"Kadhiravan","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1157\/13112944_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/375602","article-title":"Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae","volume":"37","author":"Crump","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13112944_bib10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3201\/eid0912.030230","article-title":"Ciprofloxacin treatment failure in typhoid fever case, Pakistan","volume":"9","author":"Butt","year":"2003","journal-title":"Emerg Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:11:19Z","timestamp":1588133479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X07743768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0213005X07743768"],"URL":"https:\/\/doi.org\/10.1157\/13112944","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}